Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
Clinical trial NCT01010542 · TERMINATED
Trial details
- NCT number
- NCT01010542
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-05-20
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.